Chemistry:Enbezotinib
From HandWiki
Short description: Chemical compound
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID | |
Chemical and physical data | |
Formula | C21H21FN6O3 |
Molar mass | 424.436 g·mol−1 |
3D model (JSmol) | |
| |
|
Enbezotinib (TPX-0046) is an experimental anticancer medication which acts as a RET inhibitor, as well as an inhibitor of SRC kinase.[1][2]
See also
References
- ↑ "The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046". Investigational New Drugs 40 (5): 1133–1136. October 2022. doi:10.1007/s10637-022-01259-x. PMID 35612671.
- ↑ "Precious Gene: The Application of RET-Altered Inhibitors". Molecules (Basel, Switzerland) 27 (24): 8839. December 2022. doi:10.3390/molecules27248839. PMID 36557971.
Original source: https://en.wikipedia.org/wiki/Enbezotinib.
Read more |